| Name | Title | Contact Details |
|---|
Your Challenge, Our Passion.đ Branschens i sĂ€rklass vassaste stjĂ€rnor inom e-handel, digitalisering och digital affĂ€rsutveckling under ett och samma tak - Redo att accelerera Er affĂ€r. Som experter inom E-handel, digitalisering och affĂ€rsutveckling jobbar vi bĂ„de stort och smĂ„tt, strategiskt eller operativt â alltid med tillvĂ€xt och resultat som vĂ„rt frĂ€msta fokus. Vi stöttar Er digitala resa och identifierar var ni Ă€r idag och vart ni vill vara i framtiden â med lösningarna för att verkstĂ€lla mĂ„len. Din utmaning Ă€r vĂ„r passion â vi vet vad vi pratar om, pĂ„ riktigt.
Guided Solutions connects with clients at every stage of their life, from renters insurance for their first apartment, home insurance for a newly purchased home, to running a business, all the way through their Medicare needs.
Whether youre on the road or on the water, we supply premium RV, automotive, and marine products designed to enhance your fun. Our team is committed to always thinking about your next journey â pushing the possibilities of our products and services, all to better your time spent outdoors, whenever, wherever, for years to come.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlasÂź platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-Îł), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Providing real-time asset tracking in any environment, with applications in manufacturing, defense, energy, inventory management, logistics, and security. WISERs ultra-wideband (UWB) system operates without line-of-sight and registers asset locations within inches in most cases.